- Home
- FIP vs FDMT Comparison
FIP vs FDMT Comparison
Compare FIP & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FIP | FDMT |
|---|---|---|
| Founded | 2021 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 567.5M | 476.9M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | FIP | FDMT |
|---|---|---|
| Price | $6.41 | $10.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $11.00 | ★ $34.13 |
| AVG Volume (30 Days) | ★ 880.5K | 716.4K |
| Earning Date | 01-01-0001 | 04-13-2026 |
| Dividend Yield | ★ 1.90% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $331,497,000.00 | $37,000.00 |
| Revenue This Year | $60.92 | $21,227.03 |
| Revenue Next Year | $57.57 | $161.87 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.44 | N/A |
| 52 Week Low | $3.10 | $2.24 |
| 52 Week High | $7.93 | $12.34 |
Technical Indicators
Market Signals| Indicator | FIP | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 62.03 | 63.73 |
| Support Level | $5.94 | $9.85 |
| Resistance Level | $6.72 | $11.85 |
| Average True Range (ATR) | 0.33 | 0.57 |
| MACD | -0.01 | 0.09 |
| Stochastic Oscillator | 96.33 | 78.52 |
Price Performance
Historical ComparisonAbout FIP FTAI Infrastructure Inc.
FTAI Infrastructure Inc is engaged in five segments; Railroad segment includes five freight railroads and one switching company that provide rail service to certain manufacturing and production facilities, the Jefferson Terminal segment consists of a multi-modal crude oil and refined products terminal and other related assets. Repauno segment consists of a 1,630-acre deep-water port located along the Delaware River with an underground storage cavern, a new multipurpose dock, a rail-to-ship transloading system, and multiple industrial development opportunities. Power and Gas segment is comprised of an equity method investment in Long Ridge, and Sustainability and Energy Transition segment is comprised of Aleon/Gladieux, Clean Planet, and CarbonFree.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.